Teladoc Health (TDOC) is back in focus after unveiling Teladoc One, an AI supported virtual care platform, just as new tools like ChatGPT Health raise questions about how patients seek digital health advice.

Teladoc Health’s recent Teladoc One announcement and the spotlight on ChatGPT Health come after a strong 90 day share price return of 52.52% and a year to date share price return of 24.40%, while the 5 year total shareholder return is down 94.09%, showing recent momentum against a much weaker longer term record.

If Teladoc One has you thinking about how AI is changing healthcare, this could be a good moment to see what else is out there with our 39 healthcare AI stocks

After Teladoc Health’s sharp 90 day rebound but very weak 5 year record, the key issue now is simple: is most of the rerating already in the price, or does the current valuation still leave clear upside?

Most Popular Narrative: 41.5% Undervalued

Compared to Teladoc Health’s last close at $8.77, the most followed narrative pegs fair value at $15.00, implying a large valuation gap that hinges on specific business shifts rather than broad market sentiment.

Despite the market narrative of a failing pandemic stock, Teladoc’s underlying financial engine tells a radically different story:

Teladoc is a cash-generative healthcare utility with $750M+ in hard cash protecting the downside, $130M to $170M in annual free cash flow, and an expanding insurance reimbursed mental health model.

Read the complete narrative. Read the complete narrative.

The fair value hinges on how Teladoc Health turns that cash engine and insurance focused BetterHelp model into steadier margins and a higher value multiple. Want to see which revenue mix assumptions and future profit levels sit behind that $15.00 figure, and how they feed into the discount rate used to bridge today’s price to that target.

Result: Fair Value of $15.00 (UNDERVALUED)

However, Teladoc Health’s story could shift quickly if BetterHelp’s insurance pivot compresses margins or if telehealth competitors win share faster than expected.

Next Steps

If this mix of risks and rewards around Teladoc Health feels finely balanced, take a closer look now and weigh both sides. Start with the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Teladoc Health?

Once you have formed a view on Teladoc Health, do not stop there; broadening your watchlist can help you spot opportunities you might otherwise miss.

• Target resilient income by checking out companies in the 9 dividend fortresses that may suit investors focused on cash returns.
• Hunt for potential mispriced opportunities through the 49 high quality undervalued stocks and see which stocks currently trade below their assessed worth.
• Strengthen your watchlist with the solid balance sheet and fundamentals stocks screener (49 results) to focus on companies that pair financial stability with solid fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.